![Western Blot: BST2 Antibody (2E2) [NBP2-29621] - WB analysis of BST2 protein in (A) human heart lysate (B) human ovary lysate and on (C) partial recombinant BST2 protein with monoclonal BST2 antibody at a concentration of 1 ug/ml. In the tested human lysates, two distinct bands were observed which represents the glycosylated (lower bands) and the ubiquitinated (higher bands ) forms of BST2 protein.](http://www.bioprodhub.com/system/product_images/ab_products/5/sub_7/15794_BST2-Antibody-(2E2)-Western-Blot-NBP2-29621-img0001.jpg)
Western Blot: BST2 Antibody (2E2) [NBP2-29621] - WB analysis of BST2 protein in (A) human heart lysate (B) human ovary lysate and on (C) partial recombinant BST2 protein with monoclonal BST2 antibody at a concentration of 1 ug/ml. In the tested human lysates, two distinct bands were observed which represents the glycosylated (lower bands) and the ubiquitinated (higher bands ) forms of BST2 protein.
![Immunohistochemistry-Paraffin: BST2 Antibody (2E2) [NBP2-29621] - IHC-P analysis of BST2 protein in a section of human endometrial carcinoma using 5 ug/ml concentration of BST2 antibody (clone 2E2). The carcinoma cells depicted distinct membrane-cytoplasmic BST2 positivity with more intense staining in the cellular membranes, whereas, weak staining was observed in tumor stroma.](http://www.bioprodhub.com/system/product_images/ab_products/5/sub_7/15795_BST2-Antibody-(2E2)-Immunohistochemistry-Paraffin-NBP2-29621-img0004.jpg)
Immunohistochemistry-Paraffin: BST2 Antibody (2E2) [NBP2-29621] - IHC-P analysis of BST2 protein in a section of human endometrial carcinoma using 5 ug/ml concentration of BST2 antibody (clone 2E2). The carcinoma cells depicted distinct membrane-cytoplasmic BST2 positivity with more intense staining in the cellular membranes, whereas, weak staining was observed in tumor stroma.
![Immunohistochemistry-Paraffin: BST2 Antibody (2E2) [NBP2-29621] - IHC-P analysis of BST2 protein in a section of human renal cell carcinoma (clear cell type) using 5 ug/ml concentration of BST2 antibody (clone 2E2). The carcinoma cells depicted distinct membrane-cytoplasmic BST2 positivity with more intense staining in cellular membranes.](http://www.bioprodhub.com/system/product_images/ab_products/5/sub_7/15796_BST2-Antibody-(2E2)-Immunohistochemistry-Paraffin-NBP2-29621-img0002.jpg)
Immunohistochemistry-Paraffin: BST2 Antibody (2E2) [NBP2-29621] - IHC-P analysis of BST2 protein in a section of human renal cell carcinoma (clear cell type) using 5 ug/ml concentration of BST2 antibody (clone 2E2). The carcinoma cells depicted distinct membrane-cytoplasmic BST2 positivity with more intense staining in cellular membranes.
![Immunohistochemistry-Paraffin: BST2 Antibody (2E2) [NBP2-29621] - IHC-P analysis of BST2 protein in a section of human lung cancer (squamous cell carcinoma) using 5 ug/ml concentration of BST2 antibody (clone 2E2). The carcinoma cells depicted distinct membrane-cytoplasmic BST2 positivity with more intense staining in the cellular membranes, whereas, mild to moderate staining was observed in tumor stroma also.](http://www.bioprodhub.com/system/product_images/ab_products/5/sub_7/15797_BST2-Antibody-(2E2)-Immunohistochemistry-Paraffin-NBP2-29621-img0003.jpg)
Immunohistochemistry-Paraffin: BST2 Antibody (2E2) [NBP2-29621] - IHC-P analysis of BST2 protein in a section of human lung cancer (squamous cell carcinoma) using 5 ug/ml concentration of BST2 antibody (clone 2E2). The carcinoma cells depicted distinct membrane-cytoplasmic BST2 positivity with more intense staining in the cellular membranes, whereas, mild to moderate staining was observed in tumor stroma also.